WIGTON GROUP MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: A82045 | WIGTON, CA7 9QD
Showing results 51-100 of 642
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Linagliptin | 911 | 23.5K | £26.5K | +122.4% ▲ |
| Glucose blood testing reagents | 875 | 84.4K | £11.5K | +10.9% ▲ |
| Ezetimibe | 873 | 24.9K | £4.3K | +22.7% ▲ |
| Atenolol | 871 | 28.5K | £628 | +44.5% ▲ |
| Fexofenadine hydrochloride | 848 | 36.7K | £1.7K | -0.3% vs avg |
| Venlafaxine | 847 | 34.4K | £5.1K | +0.3% vs avg |
| Lamotrigine | 824 | 48.7K | £3.6K | +39.5% ▲ |
| Amoxicillin | 811 | 38.4K | £1.0K | -13.0% ▼ |
| Montelukast | 796 | 24.5K | £1.4K | +16.3% ▲ |
| Macrogol 3350 | 795 | 37.4K | £6.3K | -15.2% ▼ |
| Doxycycline hyclate | 788 | 9,147 | £847 | +53.7% ▲ |
| Alginic acid compound preparations | 780 | 414.0K | £6.0K | +33.2% ▲ |
| Estradiol | 772 | 40.7K | £8.4K | -5.9% ▼ |
| Warfarin sodium | 764 | 29.7K | £1.1K | +62.0% ▲ |
| 763 | 431.7K | £4.5K | -22.5% ▼ | |
| Insulin aspart | 744 | 4,698 | £29.2K | +95.4% ▲ |
| 739 | 83.7K | £2.5K | +767.9% ▲ | |
| Sildenafil (Erectile Dysfunction) | 734 | 6,356 | £887 | +45.6% ▲ |
| Fluticasone propionate (Inhalation) | 728 | 780 | £14.8K | +88.1% ▲ |
| Gliclazide | 687 | 46.4K | £1.2K | -19.3% ▼ |
| Nitrofurantoin | 678 | 7,068 | £3.9K | +42.1% ▲ |
| Quetiapine | 649 | 17.7K | £11.2K | +4.2% ▲ |
| Methotrexate | 640 | 11.5K | £12.5K | +96.6% ▲ |
| Umeclidinium bromide/vilanterol | 631 | 644 | £19.9K | +223.6% ▲ |
| Sodium valproate | 625 | 99.8K | £7.5K | +96.5% ▲ |
| Senna | 622 | 25.2K | £624 | +3.4% ▲ |
| Promethazine hydrochloride | 619 | 21.8K | £2.5K | +73.2% ▲ |
| Felodipine | 612 | 18.5K | £3.0K | +3.1% ▲ |
| Flucloxacillin sodium | 596 | 27.4K | £1.4K | +32.5% ▲ |
| Indapamide | 582 | 17.4K | £715 | -32.5% ▼ |
| Fluticasone/umeclidinium/vilanterol | 574 | 584 | £24.7K | +144.8% ▲ |
| Mebeverine hydrochloride | 560 | 46.0K | £2.8K | +80.4% ▲ |
| Hydrocortisone | 557 | 17.3K | £3.2K | +24.2% ▲ |
| Mometasone furoate | 552 | 561 | £4.4K | +37.5% ▲ |
| Spironolactone | 547 | 14.9K | £1.6K | +1.5% vs avg |
| Duloxetine hydrochloride | 543 | 22.3K | £1.4K | -14.6% ▼ |
| Dapagliflozin | 542 | 15.0K | £18.6K | -56.7% ▼ |
| Latanoprost | 532 | 5,183 | £2.1K | +9.6% ▲ |
| Thiamine hydrochloride | 527 | 33.2K | £852 | +0.0% vs avg |
| Olanzapine | 520 | 7,707 | £857 | +40.4% ▲ |
| Pravastatin sodium | 504 | 14.8K | £707 | +55.2% ▲ |
| Estradiol with progestogen | 503 | 21.5K | £12.8K | +47.6% ▲ |
| 502 | 7,166 | £5.0K | -24.4% ▼ | |
| Ferrous fumarate | 501 | 29.6K | £1.2K | -30.9% ▼ |
| Desogestrel | 495 | 82.7K | £2.7K | +24.9% ▲ |
| Levetiracetam | 488 | 35.7K | £7.6K | +6.6% ▲ |
| Insulin glargine | 482 | 2,845 | £22.2K | +69.8% ▲ |
| Eplerenone | 477 | 12.9K | £1.6K | +79.9% ▲ |
| Fluticasone furoate/vilanterol | 475 | 532 | £11.7K | +206.8% ▲ |
| Esomeprazole | 469 | 18.2K | £1.4K | +15.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.